Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Flores

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 20, 2018
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca<sub>v</sub> 2.2) blockers for the treatment of painMark J Wall, Nalin L Subasinghe, Michael P Winters, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
A novel series of pyrazolylpiperidine N-type calcium channel blockersNalin L Subasinghe, Mark J Wall, Michael P Winters, et al.
Journal of Lipid Research|April 6, 2015
Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesityJohn D Douglass, Yin Xiu Zhou, Amy Wu, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2020
The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitorsBin Zhu, Peter J Connolly, Yue-Mei Zhang, et al.
Journal of Lipid Research|March 3, 2019
Erratum: Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesityJohn D Douglass, Yin Xiu Zhou, Amy Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1)Michele C Jetter, James J McNally, Mark A Youngman, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2012
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonistsJay M Matthews, Ning Qin, Raymond W Colburn, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2009
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependenceEllen E Codd, John R Carson, Raymond W Colburn, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonistsBin Zhu, Mingde Xia, Xiaoqing Xu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2005
Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer painJoseph R Ghilardi, Heidi Röhrich, Theodore H Lindsay, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|October 20, 2018
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca<sub>v</sub> 2.2) blockers for the treatment of painMark J Wall, Nalin L Subasinghe, Michael P Winters, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
A novel series of pyrazolylpiperidine N-type calcium channel blockersNalin L Subasinghe, Mark J Wall, Michael P Winters, et al.
Journal of Lipid Research|April 6, 2015
Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesityJohn D Douglass, Yin Xiu Zhou, Amy Wu, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2020
The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitorsBin Zhu, Peter J Connolly, Yue-Mei Zhang, et al.
Journal of Lipid Research|March 3, 2019
Erratum: Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesityJohn D Douglass, Yin Xiu Zhou, Amy Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1)Michele C Jetter, James J McNally, Mark A Youngman, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2012
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonistsJay M Matthews, Ning Qin, Raymond W Colburn, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2009
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependenceEllen E Codd, John R Carson, Raymond W Colburn, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonistsBin Zhu, Mingde Xia, Xiaoqing Xu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2005
Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer painJoseph R Ghilardi, Heidi Röhrich, Theodore H Lindsay, et al.
Pageof 7